KORU Medical Systems Q2 2024 Adj. EPS $(0.01) Beats $(0.04) Estimate, Sales $8.430M Beat $7.570M Estimate
KORU Medical Systems Q2 2024 Adj. EPS $(0.01) Beats $(0.04) Estimate, Sales $8.430M Beat $7.570M Estimate
2024年第二季度KORU醫療系統每股收益調整後爲$(0.01)，超過$(0.04)的預期，銷售額爲$8.43百萬，超過$7.57百萬的預期。
KORU Medical Systems (NASDAQ:KRMD) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) by 75 percent. This is a 75 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $8.430 million which beat the analyst consensus estimate of $7.570 million by 11.36 percent. This is a 21.54 percent increase over sales of $6.936 million the same period last year.
KORU Medical Systems (納斯達克：KRMD) 報告每股虧損$(0.01)，超出分析師預期的$(0.04)的75％。這比去年同期每股虧損$(0.04)增加了75％。該公司報告的季度銷售額爲$843萬，超出分析師預期的$757萬，增長了11.36％。這比去年同期的銷售額$693.6萬增長了21.54％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。